Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal COMET-2 and COMET-3 Studies.
- DOI
- 10.1016/j.ophtha.2025.09.018
- Published
- 2025-09-30
- Container
- Ophthalmology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ophtha.2025.09.018,
title = {Acoltremon Ophthalmic Solution 0.003\% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal COMET-2 and COMET-3 Studies.},
author = {Pattar GR and Wirta D and Jerkins G and Paauw J and McLaurin EB and Liu A and Evans DG and Kenyon K and Cline N and Gupta PK and Meng I and Senchyna M and COMET-2 and COMET-3 Study Groups.},
year = {2026},
journal = {Ophthalmology},
doi = {10.1016/j.ophtha.2025.09.018},
url = {https://doi.org/10.1016/j.ophtha.2025.09.018}
}RIS
TY - JOUR TI - Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal COMET-2 and COMET-3 Studies. AU - Pattar GR AU - Wirta D AU - Jerkins G AU - Paauw J AU - McLaurin EB AU - Liu A AU - Evans DG AU - Kenyon K AU - Cline N AU - Gupta PK AU - Meng I AU - Senchyna M AU - COMET-2 and COMET-3 Study Groups. PY - 2026 JO - Ophthalmology DO - 10.1016/j.ophtha.2025.09.018 UR - https://doi.org/10.1016/j.ophtha.2025.09.018 ER -
APA
GR, P., D, W., G, J., J, P., EB, M., A, L., DG, E., K, K., N, C., PK, G., I, M., M, S., & Groups., C. A. C. S. (2026). Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal COMET-2 and COMET-3 Studies.. Ophthalmology. https://doi.org/10.1016/j.ophtha.2025.09.018
Source records
- europe-pmc · retrieved 2026-09-26T09:52:11.221Z